Authors:
Riendeau, D
Percival, MD
Brideau, C
Charleson, S
Dube, D
Ethier, D
Falgueyret, JP
Friesen, RW
Gordon, R
Greig, G
Guay, J
Mancini, J
Ouellet, M
Wong, E
Xu, L
Boyce, S
Visco, D
Girard, Y
Prasit, P
Zamboni, R
Rodger, IW
Gresser, M
Ford-Hutchinson, AW
Young, RN
Chan, CC
Citation: D. Riendeau et al., Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2, J PHARM EXP, 296(2), 2001, pp. 558-566
Authors:
Wall, RK
Shelton, AH
Bonaccorsi, LC
Bejune, SA
Dube, D
McMillin, DR
Citation: Rk. Wall et al., H(2)D3: A cationic porphyrin designed to intercalate into B-form DNA (H(2)D3=trans-di(N-methylpyridium-3-yl)porphyrin), J AM CHEM S, 123(46), 2001, pp. 11480-11481
Authors:
Poiesz, B
Dube, D
Dube, S
Love, J
Papsidero, L
Uner, A
Hutchinson, R
Citation: B. Poiesz et al., Brief report: HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection, N ENG J MED, 342(13), 2000, pp. 930-936
Citation: Z. Zhang et al., Solidification microstructure of ZA102, ZA104 and ZA106 magnesium alloys and its effect on creep deformation, CAN METAL Q, 39(4), 2000, pp. 503-512
Authors:
Dube, D
Brideau, C
Deschenes, D
Fortin, R
Friesen, RW
Gordon, R
Girard, Y
Riendeau, D
Savoie, C
Chan, CC
Citation: D. Dube et al., 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridinesas selective and orally active cyclooxygenase-2 inhibitors, BIOORG MED, 9(12), 1999, pp. 1715-1720
Authors:
Angers, R
Krishnadev, MR
Tremblay, R
Corriveau, JF
Dube, D
Citation: R. Angers et al., Characterization of SiCp/2024 aluminum alloy composites prepared by mechanical processing in a low energy ball mill, MAT SCI E A, 262(1-2), 1999, pp. 9-15